ProfileGDS4814 / ILMN_1814823
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)9895.7999
GSM780708Untreated after 4 days (C2_1)9669.7599
GSM780709Untreated after 4 days (C3_1)8960.5199
GSM780719Untreated after 4 days (C1_2)9669.7599
GSM780720Untreated after 4 days (C2_2)1012699
GSM780721Untreated after 4 days (C3_2)9497.5499
GSM780710Trastuzumab treated after 4 days (T1_1)8879.2199
GSM780711Trastuzumab treated after 4 days (T2_1)1005099
GSM780712Trastuzumab treated after 4 days (T3_1)10310.199
GSM780722Trastuzumab treated after 4 days (T1_2)8903.4799
GSM780723Trastuzumab treated after 4 days (T2_2)1084599
GSM780724Trastuzumab treated after 4 days (T3_2)10503.199
GSM780713Pertuzumab treated after 4 days (P1_1)10209.699
GSM780714Pertuzumab treated after 4 days (P2_1)10209.699
GSM780715Pertuzumab treated after 4 days (P3_1)9771.5999
GSM780725Pertuzumab treated after 4 days (P1_2)1114199
GSM780726Pertuzumab treated after 4 days (P2_2)1012699
GSM780727Pertuzumab treated after 4 days (P3_2)10744.699
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)12845.299
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)10696.899
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)9853.4999
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)12677.699
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)1114199